Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Packard

Showing results (21-30 of 379) with videos related to

Pageof 38
Sort By:
Journal of Atherosclerosis and Thrombosis|April 7, 2004
Non-HDL cholesterol as a measure of atherosclerotic riskChris J Packard, Yasushi Saito
Scottish Medical Journal|July 1, 1986
The pathogenesis of hyperlipoproteinaemiaJ Shepherd, C J Packard
Current Opinion in Lipidology|August 17, 2000
At what level of coronary heart disease risk should a statin be prescribed?A Gaw, C J Packard
European Journal of Pediatrics|August 1, 1997
Studies of apolipoprotein B-100 metabolism using radiotracers and stable isotopesT Demant, C J Packard
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1994
Action of danazol on plasma lipids and lipoprotein metabolismC J Packard, J Shepherd
Current Opinion in Lipidology|February 1, 1995
Current concepts in the treatment of familial hypercholesterolaemiaC J Packard, J Shepherd
Current Opinion in Lipidology|January 19, 2016
Long-term follow-up of lipid-lowering trialsChris J Packard, Ian Ford
Arteriosclerosis (Dallas, Tex.)|January 1, 1989
Lipoprotein metabolism in familial hypercholesterolemiaJ Shepherd, C J Packard
Klinische Wochenschrift|April 15, 1985
The pathophysiology of cholesterol metabolism in manC J Packard, J Shepherd
Arteriosclerosis, Thrombosis, and Vascular Biology|January 23, 1998
Lipoprotein heterogeneity and apolipoprotein B metabolismC J Packard, J Shepherd
Pageof 38

Showing results (21-30 of 379) with videos related to

Sort By:
Pageof 38
Journal of Atherosclerosis and Thrombosis|April 7, 2004
Non-HDL cholesterol as a measure of atherosclerotic riskChris J Packard, Yasushi Saito
Scottish Medical Journal|July 1, 1986
The pathogenesis of hyperlipoproteinaemiaJ Shepherd, C J Packard
Current Opinion in Lipidology|August 17, 2000
At what level of coronary heart disease risk should a statin be prescribed?A Gaw, C J Packard
European Journal of Pediatrics|August 1, 1997
Studies of apolipoprotein B-100 metabolism using radiotracers and stable isotopesT Demant, C J Packard
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1994
Action of danazol on plasma lipids and lipoprotein metabolismC J Packard, J Shepherd
Current Opinion in Lipidology|February 1, 1995
Current concepts in the treatment of familial hypercholesterolaemiaC J Packard, J Shepherd
Current Opinion in Lipidology|January 19, 2016
Long-term follow-up of lipid-lowering trialsChris J Packard, Ian Ford
Arteriosclerosis (Dallas, Tex.)|January 1, 1989
Lipoprotein metabolism in familial hypercholesterolemiaJ Shepherd, C J Packard
Klinische Wochenschrift|April 15, 1985
The pathophysiology of cholesterol metabolism in manC J Packard, J Shepherd
Arteriosclerosis, Thrombosis, and Vascular Biology|January 23, 1998
Lipoprotein heterogeneity and apolipoprotein B metabolismC J Packard, J Shepherd
Pageof 38